Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glaxo SmithKline Sees Consumer Internet Experience Helping Rx Strategy

Executive Summary

Glaxo Wellcome is using the Internet to conduct virtual sales calls with physicians who refuse to see sales reps.

You may also be interested in...



SB/Block Deal Brings Small Rx Line, OTC Options To Glaxo Merger

SmithKline Beecham's acquisition of Block Drugs solidifies SB's number three position in the U.S. toothpaste market - and may increase the options for handling the consumer products business after the Glaxo/SmithKline merger.

SB/Block Deal Brings Small Rx Line, OTC Options To Glaxo Merger

SmithKline Beecham's acquisition of Block Drugs solidifies SB's number three position in the U.S. toothpaste market - and may increase the options for handling the consumer products business after the Glaxo/SmithKline merger.

Care Capital, LLC

Former SmithKline Beecham CEO Jan Leschly forms new investment firm in conjunction with former SB Senior VP-Information Resources John Parker and former Rhone Group Managing Director David Ramsay. The fund has co-investment arrangements with Morgan Stanley and Rho Management, and will have an initial capitalization of $100 mil. Care Capital will focus on "the impact of scientific innovation and technological development in the life sciences on the quality of healthcare." During an analysts meeting following the announcement of the Glaxo/SmithKline merger, Leschly indicated a particular interest in investment opportunities surrounding direct-to-patient communication via the Internet (1"The Pink Sheet" Jan. 31, p. 25)

Related Content

UsernamePublicRestriction

Register

PS035514

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel